HCAR2 and Parkinson disease: In addition, the current studies on some PD immune targets add confidence to our further research, such as Wnt-related signaling [62] and G protein-coupled receptor-GPR109A [63], which may more precisely ameliorate neuroinflammation in diseases such as PD by controlling tissue or organ inflammation, thereby treating or delaying disease progression.